GLRX3 and cancer: Interestingly, the existence of outliers in different cancer types (Fig. 6) suggests that additional mechanisms, besides PICOT-induced altered trimethylation of H3K27 at the CCND2 gene promoter, are likely to affect the cell cycle and growth rate of these cells.